Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexamethasone dose-ranging trial for prevention of postoperative sore throat after general anesthesia
IRCT20180416039326N23Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of dexamethasone and saline in Post-extubation sore throat (POST) (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severity of sore throat, Cough and 2 more. Started Aug 2023; status: completed.
02
Drugs
dexamethasonesaline
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on IRCT20180416039326N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N23.